Purpose-led, Performance-driven

DSM is a global science-based company operating in the fields of Nutrition, Health and Sustainable Living. Our business is centered around developing innovative solutions and large innovation projects addressing Nutrition & Health, Climate & Energy and Resources & Circularity to drive above-market growth.

Our story

DSM is positioned to drive continued above market organic growth and deliver further improvement in profitability, shareholder return and sustainability as we execute Strategy 2021.

Our performance

2018 has again been a record year in which we successfully completed Strategy 2016-2018, outperforming our ambitious financial and sustainability targets.

Shareholder information

We have recently celebrated the 30th anniversary of our privitisation and our ordinary shares being listed on the Euronext Stock Exchange in Amsterdam, the Netherlands.

Doing well financially, doing well for the world

Feike Sijbesma
CEO/Chairman Managing Board

×

Nutrition

We provide nutritional solutions for animal health and human well-being, serving the global feed, food & beverage, pharmaceutical, infant nutrition, dietary supplements and personal care industries.

2018
Sales: ↑€2,749 (2017: €2,660)
Organic Growth: ↑8%
Volume Growth: ↑4% 
Price Growth: ↑4% 

2018
Sales: ↑€1,989 (2017: €1,939)
Organic Growth: ↑7%
Volume Growth: ↑4%
Price Growth: ↑4%

2018
Sales: ↓ €490 (2017: €541)
Sales: ↓ 9%
Organic Growth: ↑1%

2018
Sales: ↑€382 (2017: €353)
Sales: ↑8%
Organic Growth: ↑11%

Sales1
€5,722m

Adjusted EBITDA1
€1,117M

Adjusted EBITDA Margin1
19.5%

1) Underlying business, net of temporary vitamin effect

Materials

Advanced and high-performance materials for the electrical & electronics, automotive, packaging, consumer goods, life protection, transportation and telecom industries.

2018
Sales: ↑€1,516 (2017: €1,448)
Organic Growth: ↑7%

2018
Sales: ↑€344 (2017: €332)
Organic Growth: ↑6%

2018
Sales: ↑€1,053 (2017: €1,045)
Organic Growth: ↑2%

Sales
€2,913M

Adjusted EBITDA
€512M

Adjusted EBITDA Margin
17.6%

Latest financial & regulatory news

Investor contacts

Our Investor Relations team are based in Heerlen, the Netherlands. The team provides key facts and figures, as well as shareholder information, to current and potential shareholders of DSM and to analysts. To that effect Investor Relations plans, prepares and organizes the written and oral communications with (potential) shareholders and financial analysts, deals with the stock exchange authorities and maintains the necessary databases, websites and brochures. 

Dave Huizing
Vice President Investor Relations
+31 45 578 2864

Anna Morello
Investor Relations Manager
+31 45 578 2282

Marc Silvertand
Investor Relations Manager
+31 45 578 2348

Daniel Uribe
Investor Relations Analyst
+31 45 578 2864

Sandra Segers
Personal Assistant
+31 45 578 2864

Petra Volk
Support Officer
+31 45 578 2511

Read more

This site uses cookies to store information on your computer.

Learn more